{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:56:50Z","timestamp":1792699010396,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T00:00:00Z","timestamp":1465862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40256-016-0177-0","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T07:37:52Z","timestamp":1465889872000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada"],"prefix":"10.1007","volume":"16","author":[{"given":"Nguyen X.","family":"Thanh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"issue":"14","key":"177_CR1","first-page":"1265","volume":"21","author":"CM Chow","year":"2005","unstructured":"Chow CM, Donovan L, Manuel D, Johansen H, Tu JV, Canadian Cardiovascular Outcomes Research Team. Regional variation in self-reported heart disease prevalence in Canada. Can J Cardiol. 2005;21(14):1265\u201371.","journal-title":"Can J Cardiol"},{"issue":"9","key":"177_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0828-282X(06)70290-2","volume":"22","author":"H Ross","year":"2006","unstructured":"Ross H, Howlett J, Arnold JM, Liu P, O\u2019Neill BJ, Brophy JM, et al. Treating the right patient at the right time: access to heart failure care. Can J Cardiol. 2006;22(9):749\u201354.","journal-title":"Can J Cardiol"},{"key":"177_CR3","volume-title":"Cardiovascular Health and Services in Ontario: An ICES Atlas","year":"1999","unstructured":"Naylor CD, Slaughter PM, editors. Cardiovascular Health and Services in Ontario: An ICES Atlas. Toronto: Institute for Clinical Evaluative Sciences; 1999."},{"issue":"2","key":"177_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurjhf\/hfq185","volume":"13","author":"JA Ezekowitz","year":"2011","unstructured":"Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics. Eur J Heart Fail. 2011;13(2):142\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"177_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0828-282X(06)70237-9","volume":"22","author":"JM Arnold","year":"2006","unstructured":"Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22(1):23\u201345.","journal-title":"Can J Cardiol"},{"key":"177_CR6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012;33:1787\u2013847.","journal-title":"Eur Heart J"},{"issue":"11","key":"177_CR7","first-page":"393","volume":"13","author":"MLL Genugten van","year":"2005","unstructured":"van Genugten MLL, Weintraub WS, Zhang Z, Voors AA. Cost-effectiveness of eplerenone plus standard treatment compared with standard treatment in patients with myocardial infarction complicated by left ventricular systolic dysfunction and heart failure in the Netherlands. Neth Heart J. 2005;13(11):393\u2013400.","journal-title":"Neth Heart J"},{"key":"177_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, Veldhuisen DJV, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11\u201321.","journal-title":"N Engl J Med"},{"issue":"18","key":"177_CR9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","volume":"59","author":"K Swedberg","year":"2012","unstructured":"Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, et al. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure) study. J Am Coll Cardiol. 2012;59(18):1598\u2013603.","journal-title":"J Am Coll Cardiol"},{"key":"177_CR10","unstructured":"Canadian Cardiovascular Society. Heart Failure Guidelines 2014. http:\/\/www.ccs.ca\/index.php\/en\/resources\/heart-failure-compendium . Accessed 1 Dec 2015."},{"issue":"21","key":"177_CR11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/heartjnl-2014-305673","volume":"100","author":"D Lee","year":"2014","unstructured":"Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, et al. Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms. Heart. 2014;100(21):1681\u20137.","journal-title":"Heart"},{"key":"177_CR12","unstructured":"Pfizer Canada Inc. Pharmacoeconomic analysis of eplerenone (inspra\u2122) as adjunct treatment for chronic heart failure. In: Common Drug Review. Eplerenone\u00a0(Inspra) (25\u00a0mg Tablet and 50\u00a0mg Tablet). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK253428\/ . Accessed 1 Dec 2015."},{"key":"177_CR13","unstructured":"Alberta Health. Overview of Administrative Health Datasets. http:\/\/www.health.alberta.ca\/documents\/Research-Health-Datasets.pdf . Accessed 8 July 2015."},{"issue":"11","key":"177_CR14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"key":"177_CR15","unstructured":"Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess. 2007;11(47):iii\u2013iv, ix\u2013248."},{"issue":"1","key":"177_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1524-4733.2008.00425.x","volume":"12","author":"A G\u00f6hler","year":"2009","unstructured":"G\u00f6hler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, et al. Utility estimates for decision-analytic modeling in chronic heart failure\u2013health states based on New York Heart Association classes and number of rehospitalizations. Value Health. 2009;12(1):185\u20137.","journal-title":"Value Health."},{"issue":"3","key":"177_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11136-010-9591-y","volume":"19","author":"J Berg","year":"2010","unstructured":"Berg J, Lindgren P, Nieuwlaat R, Bouin O, Crijns H. Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res. 2010;19(3):381\u201390.","journal-title":"Qual Life Res"},{"issue":"2","key":"177_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7020","volume":"7","author":"G Mowatt","year":"2003","unstructured":"Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess. 2003;7(2):1\u2013174.","journal-title":"Health Technol Assess"},{"issue":"6","key":"177_CR19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0272989X11401031","volume":"31","author":"PW Sullivan","year":"2011","unstructured":"Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making. 2011;31(6):800\u20134.","journal-title":"Med Decis Making"},{"key":"177_CR20","unstructured":"Alberta Health. Interactive Health Data Application. http:\/\/www.ahw.gov.ab.ca\/IHDA_Retrieval\/selectCategory.do . Accessed 30 June 2015."},{"key":"177_CR21","unstructured":"Statistics Canada. Consumer price index by province. http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/econ09a-eng.htm . Accessed 30 June 2015."},{"issue":"4","key":"177_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjcard.2004.04.059","volume":"94","author":"W Sligl","year":"2004","unstructured":"Sligl W, McAlister FA, Ezekowitz J, Armstrong PW. Usefulness of spironolactone in a specialized heart failure clinic. Am J Cardiol. 2004;94(4):443\u20137.","journal-title":"Am J Cardiol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-016-0177-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-016-0177-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-016-0177-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:14:21Z","timestamp":1589670861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-016-0177-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1007\/s40256-016-0177-0","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}